Skip to main content

Boston Scientific Corporation

FDA adverse event reports naming Boston Scientific Corporation as the device manufacturer, with recall history from the live FDA recall database. Reporter-supplied name as filed: BOSTON SCIENTIFIC CORPORATION.

Total reports
410,922
Deaths
4,666
Injuries
220,725
Malfunctions
185,429

Reports per year

12
13
14
15
16
17
18
19
20
21
22
23
24
25
26

Source: FDA adverse event reports by year received, 20122026. Reporting paused during the 2026 MAUDE-to-AEMS transition and has since resumed.

Top device categories

Recent recalls

  • 2026-07-10Open, ClassifiedUnder Investigation by firm

    Rapid Refill Continuous Injection System, UPN M00566001

    Devices contain recalled Medline Namic Angiographic Control Syringe with Rotating Adaptor. There is a risk of syringe loosening or disconnecting from the manifold, resulting in loose connection or complete disconnection. May lead to difficulty connecting syringe, inability to aspirate or inject properly, fluid leakage, or separation of the syringe from the system, potentially requiring device exchange and prolonging the procedure.

  • 2026-07-01Open, ClassifiedPackage design/selection

    CRE Pro Wireguided 6-8mm 240cm

    Potential sterile breach of the pouches in which devices are packaged.

  • 2026-07-01Open, ClassifiedPackage design/selection

    CRE Pro Wireguided 8-10mm 240cm

    Potential sterile breach of the pouches in which devices are packaged.

  • 2026-07-01Open, ClassifiedPackage design/selection

    CRE Pro Wireguided 10-12mm 240cm

    Potential sterile breach of the pouches in which devices are packaged.

  • 2026-07-01Open, ClassifiedPackage design/selection

    CRE Pro Wireguided 12-15mm 240cm

    Potential sterile breach of the pouches in which devices are packaged.

  • 2026-07-01Open, ClassifiedPackage design/selection

    CRE Pro Wireguided 15-18mm 240cm

    Potential sterile breach of the pouches in which devices are packaged.

  • 2026-07-01Open, ClassifiedPackage design/selection

    CRE Pro Wireguided 18-20mm 240cm

    Potential sterile breach of the pouches in which devices are packaged.

  • 2026-07-01Open, ClassifiedPackage design/selection

    CRE Wireguided 6-8mm 240cm

    Potential sterile breach of the pouches in which devices are packaged.

  • 2026-07-01Open, ClassifiedPackage design/selection

    CRE Wireguided 8-10mm 240cm

    Potential sterile breach of the pouches in which devices are packaged.

  • 2026-07-01Open, ClassifiedPackage design/selection

    CRE Wireguided 10-12mm 240cm

    Potential sterile breach of the pouches in which devices are packaged.

Monitor Boston Scientific Corporation automatically

DeviceWatch watches FDA adverse events and recalls for the products you care about, summarizes clinical narratives with AI and alerts you when a safety signal emerges.